FDA Drug Approvals 2013

Print 18 February 2014
Drugs.com

In 2013, the U.S. Food and Drug Administration (FDA) approved 27 New Molecular Entities (NMEs). According to the FDA, an NME contains an active ingredient that has not been previously approved, either as a single ingredient drug or as part of a combination product. These products frequently provide important new therapies for patients. In fact, three medications approved at the end of 2013 were newly designated "Breakthrough Therapies" - products that demonstrate substantial improvement over existing therapies and are used to treat a serious or life threatening condition. Follow along to see all the 2013 approvals and their unique uses.

More information

Source

Return